pleconaril
Sign in to savePleconaril (Picovir) is an antiviral drug that was being developed by Schering-Plough for prevention of asthma exacerbations and common cold symptoms in patients exposed to picornavirus respiratory infections. Pleconaril, administered either orally or intranasally, is active against viruses in the Picornaviridae family, including Enterovirus and Rhinovirus. It has shown useful activity against the dangerous enterovirus D68.
Article
7 sectionsContents
- History
- Mechanism of action
- Clinical trials
- Resistance
- Side effects
- See also
- References
{{Drugbox | Verifiedfields = changed | verifiedrevid = 464208620 | IUPAC_name = 3-{3,5-dimethyl-4-[3-(3-methylisoxazol-5-yl)propoxy]phenyl}-5-(trifluoromethyl)-1,2,4-oxadiazole | image = Pleconaril.svg | image_class = skin-invert-image | width = 250px | image2 = Pleconaril ball-and-stick model.png | image_class2 = bg-transparent
| tradename = | pregnancy_AU = | pregnancy_US = | pregnancy_category = | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = ? | routes_of_administration = Oral, intranasal